AARON D ESTEP
Allopathic & Osteopathic Physicians|Family Medicine BELPRE, OH NPI 1841753936
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine OH Insulet Corporation All categories
General Payments — all program years on this page
$302.47
- Category: General Payments
- Program years: PY2023–2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $265.81 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $265.81 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $155.54 | 1 |
| Novo Nordisk AS | $30.27 | 1 |
| Corcept Therapeutics | $20.91 | 1 |
| Lilly USA, LLC | $16.50 | 1 |
| DEXCOM, INC. | $14.70 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.24 | 1 |
| Ascensia Diabetes Care US Inc. | $13.65 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086955337 | Novartis Pharmaceuticals Corporation | $14.24 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089094179 | Ascensia Diabetes Care Us Inc. | $13.65 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097066234 | Novo Nordisk Inc | $30.27 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116815903 | Insulet Corporation | $155.54 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117758763 | Corcept Therapeutics | $20.91 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136002385 | Lilly USA, LLC | $16.50 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153275748 | Dexcom, Inc. | $14.70 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.